2010107G23Rik Activators
2010107G23Rik Activators are a collection of chemical compounds that indirectly amplify the functional activity of 2010107G23Rik through diverse signaling pathways. The activators such as Forskolin, which raises cAMP levels, and PMA, a PKC activator, both contribute to the enhancement of 2010107G23Rik by stimulating protein kinases that can phosphorylate substrates within the signaling cascade that 2010107G23Rik is a part of. This facilitation is critical to the functional outcomes that 2010107G23Rik influences. Additionally, the kinase inhibitors Epigallocatechin gallate and Staurosporine, despite their generalist targets, selectively promote the activity of 2010107G23Rik by inhibiting kinases that otherwise negatively regulate the protein's pathways. They create a favorable signaling environment for 2010107G23Rik's activity by reducing competitive signaling interference.
Moreover, compounds that modulate intracellular secondary messengers, such as Sphingosine-1-phosphate, Thapsigargin, and A23187, indirectly enhance 2010107G23Rik's activity by initiating signaling cascades that intersect with the protein's functional spectrum. The lipid signaling molecule Sphingosine-1-phosphate and the calcium signaling modulators Thapsigargin and A23187 recalibrate intracellular environments to potentiate the processes governed by 2010107G23Rik. Inhibitors like LY294002, U0126, SB203580, and Wortmannin play an integral role by dampening competing survival pathways or inhibiting specific kinases, thereby shifting the cellular signaling balance in favor of pathways where 2010107G23Rik acts as a crucial component. Collectively, the biochemical actions of these activators converge to enhance the functional capacity of 2010107G23Rik without directly increasing its expression levels or through direct binding activation, ensuring the promotion of the protein's native and essential cellular functions.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
This catechin inhibits kinases that negatively regulate signaling pathways involving 2010107G23Rik. By doing so, it reduces competition from other signaling molecules, enhancing the functional activity of 2010107G23Rik. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
As a PI3K inhibitor, LY294002 suppresses competing survival pathways, indirectly enhancing pathways that are positively regulated by 2010107G23Rik, thus fostering its functional role. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Through its role as a lipid signaling molecule, Sphingosine-1-phosphate can activate signaling cascades that indirectly enhance the activity of 2010107G23Rik by modulating the cellular environment in which 2010107G23Rik operates. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Although a broad-spectrum kinase inhibitor, Staurosporine can lead to the selective activation of pathways involving 2010107G23Rik by inhibiting kinases that negatively modulate 2010107G23Rik-related pathways. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein functions as a tyrosine kinase inhibitor, allowing pathways in which 2010107G23Rik is involved to become more active by reducing competition from tyrosine kinase signaling. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin increases intracellular calcium levels, activating calcium-dependent signaling pathways crucial for processes in which 2010107G23Rik is implicated, thus augmenting its activity. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
This calcium ionophore increases intracellular calcium levels, similarly to Thapsigargin, and thus activates calcium-dependent signaling pathways enhancing the activity of 2010107G23Rik. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
As a PKC activator, PMA enhances the activity of 2010107G23Rik by promoting signaling pathways in which PKC is a positive regulator of processes that 2010107G23Rik is involved in. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
This p38 MAPK inhibitor indirectly enhances the functional activity of 2010107G23Rik by inhibiting pathways that compete or negatively regulate the signaling processes involving 2010107G23Rik. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin, another PI3K inhibitor like LY294002, suppresses competitive signaling pathways, thereby indirectly enhancing the functional role of 2010107G23Rik in its associated signaling pathways. | ||||||